Evidence map›Paper›PMID 40733716›Full record

ArticleVaccines2025

Nuclear Factor Erythroid 2-Related Factor 2 and SARS-CoV-2 Infection Risk in COVID-19-Vaccinated Hospital Nurses.

Stefano Rizza, Luca Coppeta, Gianluigi Ferrazza, Alessandro Nucera, Maria Postorino, Andrea Quatrana, Cristiana Ferrari, Rossella Menghini, Susanna Longo, Andrea Magrini and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stefano RizzaDepartment of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0001-5496-4890
Luca CoppetaDepartment of Occupational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0003-2470-6107
Gianluigi FerrazzaDepartment of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Alessandro NuceraDepartment of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Maria PostorinoDepartment of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Andrea QuatranaDepartment of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-0683-3009
Cristiana FerrariDepartment of Occupational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-2292-3338
Rossella MenghiniDepartment of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Susanna LongoDepartment of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-7353-245X
Andrea MagriniDepartment of Occupational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Massimo FedericiDepartment of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.

Funding

European Union's Seventh Framework Programme n° 278397PRIN (Progetti di Ricerca di Interesse Nazionale, Italy) 2022 n° 20229PX74A_004
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-S-RBD IgG antibodyBNT162b2 mRNA vaccineCOVID-19healthcare workersSARS-CoV-2vaccine

Identifiers

PMID40733716
PMCPMC12300208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.